Forecast: Hospital Discharges for Dorsalgia Cases in France

In 2023, hospital discharges for dorsalgia cases in France stood at 70.0 units per hundred thousand persons. From 2024 to 2028, a consistent decrease is forecasted, with values declining from 69.4 to 65.5 discharges. The year-on-year variations show a decreasing trend by approximately 2% per year. Over the five-year period, the compound annual growth rate (CAGR) indicates a steady reduction in discharges.

Future trends to watch for:

  • Advancements in medical treatments and preventive care which may further reduce hospital discharges.
  • Potential changes in healthcare policy influencing patient management strategies.
  • Increased awareness and intervention efforts in ergonomics and workplace health management could impact the frequency of dorsalgia cases.

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease